# VivoSim Labs, Inc. (VIVS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VIVS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 145.4K | $ -1.26M | $ -10.88M | $ 577.0K | $ 4.44M |
| 2024 | $ 128.2K | $ -13.02M | $ -10.63M | $ 1.06M | $ 364.0K |
| 2023 | $ 261.7K | $ -20.64M | $ -18.29M | $ 1.50M | $ 6.18M |
| 2022 | $ 1.91M | $ -13.08M | $ -10.62M | $ 1.90M | $ 22.29M |
| 2021 | $ 0 | $ -14.42M | $ -11.28M | $ 2.27M | $ 31.29M |
| 2020 | $ 0 | $ -21.60M | $ -18.37M | $ 0 | $ 20.75M |
| 2019 | $ 3.71M | $ -29.65M | $ -21.67M | $ 0 | $ 28.95M |
| 2018 | $ 4.64M | $ -35.79M | $ -27.84M | $ 0 | $ 35.68M |
| 2017 | $ 5.81M | $ -51.21M | $ -41.66M | $ 0 | $ 48.60M |
| 2016 | $ 5.46M | $ -49.75M | $ -42.59M | $ 0 | $ 70.90M |
| 2015 | $ 1.69M | $ -53.36M | $ -41.90M | $ 0 | $ 69.04M |
| 2014 | $ 592.1K | $ -40.65M | $ -28.80M | $ 8.0K | $ 48.31M |
| 2013 | $ 681.3K | $ -50.47M | $ -18.84M | $ 18.0K | $ 48.70M |
| 2012 | $ 1.73M | $ -62.88M | $ -14.51M | $ 27.0K | $ -5.30M |
| 2011 | $ 2.5K | $ -233.9K | $ -104.7K | $ 9.5K | $ -70.8K |
| 2010 | $ 0 | $ -110.8K | $ -119.2K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.13 |
| Liabilities / Eq | 0.57 |
| Current Ratio | 2.44 |

## Other views

- [Metrics](https://sponda.capital/en/VIVS.md)
- [Charts](https://sponda.capital/en/VIVS/charts.md)
- [Compare](https://sponda.capital/en/VIVS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.